関連する実験動画
Updated: Jun 1, 2026

07:44
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
ワクチンの次の10年:社会的,科学的課題
E Richard Moxon1, Claire-Anne Siegrist
1University of Oxford Department of Paediatrics, John Radcliffe Hospital, Oxford, UK.
Lancet (London, England)
|June 14, 2011
まとめ
将来のワクチンは,ウイルスおよび細菌疾患を超えて,寄生虫および真菌感染症を含むように拡張されます. これらの新種の予防接種を開発するには,免疫学をより深く理解し,ワクチンの安全性と有効性に対する公衆の信頼に対処する必要があります.
科学分野:
- 免疫学とワクチン開発
- 微生物学 微生物学とは
- 公共衛生は公衆衛生である.
背景:
- ワクチンは,微生物疾患を予防することによって,世界的な健康状態を大幅に改善しました.
- 科学の進歩は,ウイルス,細菌,寄生虫,および真菌疾患に対する新しいワクチンの機会を提供します.
- ワクチンの安全性や開発機関に対する公衆の信頼と信頼は,公衆衛生上の利益を実現するために極めて重要です.
研究 の 目的:
- ワクチン開発における将来の機会と課題を探求する.
- 高い病原体変異性を持つ病気と戦うための革新的なアプローチの必要性を強調する.
- 効果的で安全なワクチンを設計するための免疫学的課題を理解することの重要性を強調する.
主な方法:
- 過去のワクチン開発戦略のレビュー.
- 現在の科学技術進歩の分析.
- 免疫学的課題,宿主遺伝,環境要因を考慮する.
主要な成果:
- 将来のワクチンは,自然免疫がしばしば無効であるHIVやマラリアなどの病気に対処する必要があります.
- 脆弱な集団 (高齢者,免疫低下者) のためのワクチンの開発は,将来の重要な方向です.
- パーソナライズされたアプローチと合理的な補助剤の設計は,新しいワクチンの開発に不可欠です.
結論:
- ワクチンのポートフォリオを拡大するための重要な科学的機会が存在します.
- 病原体の変動性と公衆の信頼に関連する課題を克服することが不可欠です.
- 免疫学のより深い理解は,次世代の安全で効果的なワクチンの開発に不可欠です.
関連する概念動画
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccinations
Overview
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...

